{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:10:30Z","timestamp":1791403830309,"version":"4.3.3"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T00:00:00Z","timestamp":1748304000000},"content-version":"am","delay-in-days":360,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.neulet.2024.137828","type":"journal-article","created":{"date-parts":[[2024,5,19]],"date-time":"2024-05-19T14:00:43Z","timestamp":1716127243000},"page":"137828","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Basmisanil, an \u03b15-GABAAR negative allosteric modulator, produces rapid and sustained antidepressant-like responses in male mice"],"prefix":"10.1016","volume":"833","author":[{"given":"Fernanda","family":"Daher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narcy A.","family":"Villalobos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Hanley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Atack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana O.","family":"Popa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4212-7424","authenticated-orcid":false,"given":"Manoela V.","family":"Foga\u00e7a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.neulet.2024.137828_b0005","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1001\/archpsyc.62.6.617","article-title":"Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication","volume":"62","author":"Kessler","year":"2005","journal-title":"Arch Gen Psychiatry"},{"issue":"2","key":"10.1016\/j.neulet.2024.137828_b0010","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/15622970701227829","article-title":"World federation of societies of biological psychiatry (wfsbp) guidelines for biological treatment of unipolar depressive disorders in primary care","volume":"8","author":"Bauer","year":"2007","journal-title":"World J Biol Psychiatry"},{"issue":"4","key":"10.1016\/j.neulet.2024.137828_b0015","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","article-title":"Antidepressant effects of ketamine in depressed patients","volume":"47","author":"Berman","year":"2000","journal-title":"Biol Psychiatry"},{"issue":"8","key":"10.1016\/j.neulet.2024.137828_b0020","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression","volume":"63","author":"Zarate","year":"2006","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"10.1016\/j.neulet.2024.137828_b0025","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1360-0443.2011.03576.x","article-title":"D. Independent Scientific Committee on, Ketamine use: a review","volume":"107","author":"Morgan","year":"2012","journal-title":"Addiction"},{"issue":"2","key":"10.1016\/j.neulet.2024.137828_b0030","first-page":"84","article-title":"Novel benzodiazepine-like ligands with various anxiolytic, antidepressant, or pro-cognitive profiles","volume":"5","author":"Prevot","year":"2019","journal-title":"Mol Neuropsychiatry"},{"issue":"1","key":"10.1016\/j.neulet.2024.137828_b0035","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0285-16.2017","article-title":"A negative allosteric modulator for alpha5 subunit-containing gaba receptors exerts a rapid and persistent antidepressant-like action without the side effects of the nmda receptor antagonist ketamine in mice","volume":"4","author":"Zanos","year":"2017","journal-title":"eNeuro"},{"key":"10.1016\/j.neulet.2024.137828_b0040","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3389\/fnmol.2019.00179","article-title":"Neurobiology and therapeutic potential of alpha5-GABA type a receptors","volume":"12","author":"Jacob","year":"2019","journal-title":"Front Mol Neurosci"},{"issue":"9","key":"10.1016\/j.neulet.2024.137828_b0045","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.tips.2023.06.009","article-title":"GABA(A) receptors as targets for treating affective and cognitive symptoms of depression","volume":"44","author":"Luscher","year":"2023","journal-title":"Trends Pharmacol Sci"},{"issue":"3","key":"10.1016\/j.neulet.2024.137828_b0050","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.biopsych.2021.11.024","article-title":"Negative allosteric modulation of gamma-aminobutyric acid a receptors at alpha5 subunit-containing benzodiazepine sites reverses stress-induced anhedonia and weakened synaptic function in mice","volume":"92","author":"Troppoli","year":"2022","journal-title":"Biol Psychiatry"},{"issue":"11","key":"10.1016\/j.neulet.2024.137828_b0055","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1038\/npp.2015.112","article-title":"Rapid antidepressant action and restoration of excitatory synaptic strength after chronic stress by negative modulators of alpha5-containing GABAA receptors","volume":"40","author":"Fischell","year":"2015","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.neulet.2024.137828_b0060","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.pharmthera.2009.09.001","article-title":"Preclinical and clinical pharmacology of the GABAA receptor alpha5 subtype-selective inverse agonist alpha5IA","volume":"125","author":"Atack","year":"2010","journal-title":"Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.neulet.2024.137828_b0065","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1124\/jpet.109.157636","article-title":"In vitro and in vivo properties of 3-tert-butyl-7-(5-methylisoxazol-3-yl)-2-(1-methyl-1H-1,2,4-triazol-5-ylmethoxy)- pyrazolo[1,5-d]-[1,2,4]triazine (MRK-016), a GABAA receptor alpha5 subtype-selective inverse agonist","volume":"331","author":"Atack","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"issue":"5","key":"10.1016\/j.neulet.2024.137828_b0070","first-page":"359","article-title":"Characterization of the solubility of a poorly soluble hydroxylated metabolite in human urine and its implications for potential renal toxicity","volume":"60","author":"Merschman","year":"2005","journal-title":"Pharmazie"},{"issue":"1","key":"10.1016\/j.neulet.2024.137828_b0075","doi-asserted-by":"crossref","first-page":"7700","DOI":"10.1038\/s41598-021-87307-7","article-title":"Basmisanil, a highly selective GABA(A)-alpha5 negative allosteric modulator: preclinical pharmacology and demonstration of functional target engagement in man","volume":"11","author":"Hipp","year":"2021","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.neulet.2024.137828_b0080","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s11689-022-09418-0","article-title":"A randomized, double-blind, placebo-controlled phase II trial to explore the effects of a GABA(A)-alpha5 NAM (basmisanil) on intellectual disability associated with Down syndrome","volume":"14","author":"Goeldner","year":"2022","journal-title":"J Neurodev Disord"},{"issue":"5994","key":"10.1016\/j.neulet.2024.137828_b0085","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1126\/science.1190287","article-title":"mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists","volume":"329","author":"Li","year":"2010","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.neulet.2024.137828_b0090","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1038\/s41380-020-00916-y","article-title":"Inhibition of GABA interneurons in the mPFC is sufficient and necessary for rapid antidepressant responses","volume":"26","author":"Fogaca","year":"2021","journal-title":"Mol Psychiatry"},{"issue":"9","key":"10.1016\/j.neulet.2024.137828_b0095","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1038\/s41386-023-01583-7","article-title":"M1 acetylcholine receptors in somatostatin interneurons contribute to GABAergic and glutamatergic plasticity in the mPFC and antidepressant-like responses","volume":"48","author":"Fogaca","year":"2023","journal-title":"Neuropsychopharmacology"},{"issue":"10","key":"10.1016\/j.neulet.2024.137828_b0100","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1038\/mp.2017.220","article-title":"BDNF release and signaling are required for the antidepressant actions of GLYX-13","volume":"23","author":"Kato","year":"2018","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.neulet.2024.137828_b0105","article-title":"Cell-type specific modulation of NMDA receptors triggers antidepressant actions","author":"Pothula","year":"2020","journal-title":"Mol Psychiatry"},{"issue":"4","key":"10.1016\/j.neulet.2024.137828_b0110","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/s41592-022-01443-0","article-title":"Multi-animal pose estimation, identification and tracking with DeepLabCut","volume":"19","author":"Lauer","year":"2022","journal-title":"Nat Methods"},{"key":"10.1016\/j.neulet.2024.137828_b0115","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.pbb.2018.10.005","article-title":"Comparison of rapid and long-lasting antidepressant effects of negative modulators of alpha5-containing GABAA receptors and (R)ketamine in a chronic social defeat stress model","volume":"175","author":"Xiong","year":"2018","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.neulet.2024.137828_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2023.114554","article-title":"Changes in social, sexual, and hedonic behaviors in rats in response to stress and restoration by a negative allosteric modulator of alpha5-subunit containing GABA receptor","volume":"452","author":"Bailey","year":"2023","journal-title":"Behav Brain Res"},{"issue":"6","key":"10.1016\/j.neulet.2024.137828_b0125","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1093\/ijnp\/pyx003","article-title":"Selective pharmacological augmentation of hippocampal activity produces a sustained antidepressant-like response without abuse-related or psychotomimetic effects","volume":"20","author":"Carreno","year":"2017","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.neulet.2024.137828_b0130","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3389\/fncel.2019.00087","article-title":"Cortical GABAergic dysfunction in stress and depression: new insights for therapeutic interventions","volume":"13","author":"Fogaca","year":"2019","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.neulet.2024.137828_b0135","doi-asserted-by":"crossref","DOI":"10.1038\/s41380-019-0400-x","article-title":"Neurobiology of rapid-acting antidepressants: convergent effects on GluA1-synaptic function","author":"Duman","year":"2019","journal-title":"Mol Psychiatry"},{"issue":"2","key":"10.1016\/j.neulet.2024.137828_b0140","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0014-5793(90)80118-3","article-title":"Functional expression and sites of gene transcription of a novel alpha subunit of the GABAA receptor in rat brain","volume":"260","author":"Malherbe","year":"1990","journal-title":"FEBS Lett"}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394024002064?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394024002064?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T17:06:09Z","timestamp":1734627969000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394024002064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":28,"alternative-id":["S0304394024002064"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2024.137828","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Basmisanil, an \u03b15-GABAAR negative allosteric modulator, produces rapid and sustained antidepressant-like responses in male mice","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neulet.2024.137828","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"137828"}}